When selecting a new contract manufacturer for a biomanufacturing project, Manufacturing/Production personnel hold the greatest average influence at 18%, according to ISR’s Bioprocessing Market Outlook 2025–2030. Executive Management and R&D follow closely, each accounting for 15% of decision-making influence.
Department Influence on CDMO Selection
(Average % allocated by 100 respondents)
The remaining influence is distributed across seven additional functions, with no single department accounting for more than a fifth of total influence. The data are drawn from 100 respondents at pharma and biotech companies with active biologic outsourcing responsibilities, surveyed across North America, Europe, and Asia in Q3 2025.
Source: ISR, Bioprocessing Market Outlook: 2025–2030 (5th Edition)
